Join us for two exciting seminars from Michael D. Ehlers, MD, PhD, an internationally recognized neuroscientist, biotechnology executive, and biotech company founder. He currently serves as an entrepreneur partner at MPM BioImpact, where he directs the fund’s science-driven investment strategy by identifying and evaluating new breakthrough science around the world. Ehlers is CEO and co-founder of Ascidian Therapeutics, a clinical-stage RNA editing company developing exon-editing technologies for hereditary diseases, and CEO of a stealth-stage company pursuing next-generation RNA therapeutics.
Ehlers’ previous experience includes co-founding multiple biotechnology companies, holding major research and development roles, and advancing clinical programs for therapeutic drug development. Earlier in his career, Ehlers was George Barth Geller Professor and a Howard Hughes Medical Institute Investigator at Duke University, pioneering influential work on neuronal organelles and neurotransmitter receptor trafficking. He has authored over 100 scientific papers, received major awards including the Eppendorf & Science Prize in Neurobiology and the Thudichum Medal, and serves on multiple academic, foundation, and biotech advisory boards.
Join us to learn about Ehlers’ career trajectory, scientific discoveries, and lessons learned along the way.
Event Schedule on Monday, April 13
Career Seminar: "I Didn’t Plan This Career … and That’s the Point: One Scientist’s Path Through Academia, Biopharma, & Venture Creation"
1:30 p.m.
4MLK Building
Research Talk: "Primordial Origins of RNA Therapeutics"
4 p.m.
University of Maryland School of Dentistry, Room G310
Please note: These are in-person sessions. A virtual option will not available.
This seminar series is jointly hosted by:
- Office of Graduate and Postdoctoral Training and Advancement, University of Maryland School of Medicine (UMSOM)
- University of Maryland Medicine Institute for Neuroscience Discovery (UM-MIND)
- Center for Advanced Research Training & Innovation (CARTI), UMSOM
- UM Ventures
- Department of Pharmacology & Physiology, UMSOM